Table 3.
Laboratory Examinations and Radiological Findings Between the Two Groups
| Non-IPM (n=66) | IPM (n=65) | P-value | |
|---|---|---|---|
| WBC, *10^9/L | 7.73±5.07 | 7.37±3.86 | 0.643 |
| Neutrophils, *10^9/L | 7.85±10.72 | 6.13±3.68 | 0.224 |
| N% | 73.77±19.56 | 80.79±11.96 | 0.015 |
| Lymphocyte, *10^9/L | 1.09±0.74 | 0.82±0.59 | 0.023 |
| L% | 17.01±11.68 | 13.30±8.53 | 0.04 |
| RBC, *10^12/L | 4.28±0.69 | 3.94±1.00 | 0.023 |
| Hemoglobin, g/mL | 133.41±40.87 | 120.11±25.36 | 0.027 |
| Platelets, *10^9/L | 191.39±109.60 | 155.14±78.29 | 0.031 |
| CRP, mg/L | 9.70±7.54 | 12.58±12.43 | 0.111 |
| ESR, mm/h | 23.69±18.85 | 26.23±20.48 | 0.462 |
| PCT, ng/mL | 9.3±31.40 | 8.09±32.73 | 0.83 |
| BUN, mmol/L | 6.95±4.78 | 8.33±5.68 | 0.133 |
| Creatinine, µmol/L | 90.59±76.81 | 105.31±109.67 | 0.375 |
| Fasting blood glucose on admission, mmol/L | 8.57±5.40 | 7.93±3.51 | 0.42 |
| ALT, U/L | 46.59±52.53 | 52.03±57.14 | 0.572 |
| AST, U/L | 100.61±231.90 | 95.05±136.55 | 0.868 |
| Albumin, g/L | 32.89±5.13 | 30.53±4.36 | 0.005 |
| Total protein, g/L | 60.48±8.36 | 57.94±9.83 | 0.112 |
| Direct Bilirubin, umol/L | 10.29±17.60 | 7.44±6.87 | 0.224 |
| Indirect bilirubin, umol/L | 6.67±3.39 | 9.14±22.97 | 0.39 |
| CK, U/L | 284.77±625.90 | 350.78±511.13 | 0.51 |
| CK-MB, ng/mL | 1.95±4.009 | 1.98±3.306 | 0.964 |
| LDH, U/L | 575.53±527.71 | 608.72±406.60 | 0.688 |
| D-dimer, mg/L | 7.01±10.34 | 17.04±87.72 | 0.358 |
| TT, S | 19.67±5.16 | 19.55±2.79 | 0.87 |
| APTT, S | 32.39±10.63 | 32.16±9.37 | 0.896 |
| PT, S | 13.24±4.35 | 13.85±9.30 | 0.631 |
| Fibrinogen, mg/L | 424.24±190.70 | 385.96±141.97 | 0.195 |
| CD4+ T cell, cell/μL | 398.92±271.75 | 238.54±149.27 | 0 |
| CD8+ T cell, cell/μL | 217.11±165.50 | 147.45±85.91 | 0.003 |
| CD4+ T cell /CD8+ T cell | 2.24±1.30 | 1.86±1.07 | 0.073 |
| Pleural effusion, n | 33 | 39 | 0.25 |
| Imaging | 0.537 | ||
| Ground-glass attenuation, n | 33 | 26 | |
| Consolidation, n | 33 | 39 | |
| G test, n | 14 | 15 | 0.87 |
| GM test, n | 13 | 21 | 0.123 |
| Complicated arrhythmia, n | 8 | 7 | 0.808 |
| Bacterial co-infection, n | 15 | 30 | 0.007 |
| Steroid use after admission, n | 25 | 18 | 0.153 |
| Antibiotic combination, n | 50 | 53 | 0.637 |
| Influenza virus type | 0.545 | ||
| Influenza A, n | 56 | 59 | |
| Influenza B, n | 6 | 3 | |
| Influenza A±B, n | 3 | 4 |